Juno Therapeutics Inc Securities Litigation (2018)

Juno Therapeutics, Inc. ("Juno") is a biopharmaceutical company focused on developing cell-based cancer immunotherapies.

See Case Details »

Ohr Pharmaceutical, Inc. Securities Litigation

Ohr is a clinical stage pharmaceutical company developing novel therapies for ophthalmic diseases. Ohr's lead candidate, Squalamine (or squalamine lactate ophthalmic solution, 0.2%, or OHR-102), is a novel therapeutic product aiming at providing a non-invasive therapy to improve vision outcomes.

See Case Details »

Cascadian Therapeutics, Inc. Securities Litigation

According to the Complaint, Cascadian Therapeutics, Inc. ("Cascadian") is a clinical-stage biopharmaceutical company. Cascadian focuses on the development of therapeutic products for the treatment of cancer.

See Case Details »

NQ Mobile Securities Litigation

NQ Mobile provides internet services in the People's Republic of China ("PRC") and internationally.

See Case Details »

Aflac Incorporated Securities Litigation

Aflac is a Fortune 500 company servicing more than 50 million people worldwide. The Company is authorized to conduct insurance business in all 50 states, the District of Columbia, several U.S. territories and Japan. Aflac offers voluntary insurance policies designed to supplement traditional health insurance and protect individuals from depletion of assets and loss-of-income. Its products include insurance plans for accidents, cancer, critical illness/care, hospital indemnity, fixed-benefit dental, vision care, life and short-term disability.

See Case Details »